Diabetes diagnosis: Clarifying HbA1c thresholds and diagnostic standards

Medical discussions regarding diabetes diagnosis and HbA1c thresholds have recently highlighted the importance of accurate diagnostic standards. A viral social media claim incorrectly asserted that 2018 American College of Physicians (ACP) guidelines redefined diabetes to include HbA1c levels up to 8.4% and post-prandial glucose up to 250 mg/dL as normal. In reality, the ACP guidance was strictly intended for managing patients already diagnosed with Type 2 diabetes to avoid hypoglycemia, rather than redefining diagnostic criteria. Major organizations like the World Health Organization and the American Diabetes Association maintain that an HbA1c of 6.5% or higher indicates diabetes.

In a separate clinical context, research conducted in South Africa suggests that standard HbA1c thresholds, which are often based on populations of European ancestry, may need adjustment for different demographics. A study of Black adults in Mpumalanga found that an HbA1c threshold of 6.1% provided the best balance of sensitivity and specificity when compared to oral glucose tolerance tests, while a 6.0% threshold performed well against fasting glucose levels. The findings emphasize the necessity of adapting diagnostic thresholds to local populations to improve accuracy.